$SIGA BULLISH as Monkeypox is spreading around the worldNice breakout from that bullish pennant flag🔥
Monkeypox might be the next Pandemic (according to WHO) and $SIGA might be the next $MRNA (5000% up since the beginning of Covid)🚀📈
PFE
Pfizer at resistancePfizer
Short Term - We look to Sell at 54.62 (stop at 56.31)
Bespoke resistance is located at 54.70. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. Trading has been mixed and volatile.
Our profit targets will be 49.84 and 46.85
Resistance: 54.70 / 56.32 / 61.71
Support: 50.00 / 47.50 / 40.94
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
$PFE Call Sweeps and ER next week hmmmPfizer has ER next week and 5/20 calls sweeping today
Technically it looks like we can get a run up to ER , as PFE is at trendline support and possible "fill out" of the triangle pattern
Any run up will capture some gains, will trim position and leave a few runners for ER.
Sweeps were 55.5 and 57 strike which are pretty far out the money, worth noting. Could just be a traders Lotto on $37K of premium (must be nice haha)
Cheers
It's a small trendline break but I'll take it.I took a small CALL option position this morning. Got the 5/13 $8 calls for $1.20. Now $1.65.
BIIB and PFE both report in the morning.
Shorting it to Ground MRNA
We likely see a relief rally which will carry all stocks.
We saw after hour that $FB missed earning but rallied anyway.
Denmark announced today that it is ending all COVID treatment.
thecountersignal.com
Expect other progressive governments to follow suit - although their probably not that many anymore.
Sure you could look at the excess deaths that can't explained and say I'm shorting this experimental drug company.
The attached chart makes a convincing argument. This is a chart of the US excess deaths which can not be explained.
twitter.com - great graphic take a second to view it.
That said I expect Moderna to rally one last time.
I've personally bought back a few options contracts but will be looking to sell more at the .38 Fib at the top the triangle.
Unlike Pfizer which has deep pipeline of drugs - Moderna only has drugs in clinical trials, without the Vaccines they have NO income.
I have very strong feeling about this company but again, I expect it to rally - and from there I will be selling more.
You have to decide for yourself is this doctor lying?
twitter.com
NOTE: stretch this chart out to view it property. Looks good on my 32 DELL monitors but when posted the chart is compressed
$PFE: Big weekly trend setting up...I think $PFE offers a tremendous opportunity here, good setup to enter a position with low risk vs reward potential. Could be a long term position as well, depending on how it evolves.
I'm long 12.07% here, risking a 3 times the daily ATR move against me for a 1% loss if it drops that much. Valuation is attractive and long term charts have a huge setup in $PFE, the big correction as of late seems to be over, and it's ready to go steadily up again.
Best of luck,
Ivan Labrie.
PFE: Sell Zone is 58-60Pfizer's W-4 bottomed right in our "Buy Zone" and has bounced 10% since. I expect Pfizer to continue to climb up to the $58-60 level over the coming 2 weeks or so. After that, Pfizer will pull back for it's larger degree W-2, which should bring price back to about the $50 level. We will have more clarity on pullback targets once W-5 tops, most likely in our "selling zone". The point is, this is not an idea time to start a position. I will be selling covered calls against my shares of Pfizer when we reach the selling zone, and will be looking to add shares for about $50 sometime in Late May/Early June.
Pfizer: Buy Zone is 50-52Pfizer is still working on its 5-wave move off the low. Over the next few days it should finish up this W-4 which would take price to the 50-52 region at least. After that, I expect Pfizer should complete its 5-wave move with a push up to about the 58-60 level. However, after that it should return to approximately current levels again, so there will be plenty of opportunity to accumulate shares over the next couple weeks. I suspect this stock can reach 70-80 range this year.
Moderna - Short it into the Ground Never have I used this platform to message outside of what I believed Future contract or stock could do in the future.
Till now. There is a trade here too.
The tweet is from Robert F. Kennedy Jr. - confidant sure you recognize the name hence why I choose this one. (Although there are 100's)
Nice video explaining what's going on, and what the plan is going forward. Just in case you are not aware.
$PFE and $MRNA use the same tech to modify Human RNA (ribonucleic acid.) They're clinical trials are marred in fraud, they have made billions, and would be exempt from litigation except they lied about the safety of their products.
Why short Moderna instead of Pfizer? Pfizer has full pipeline of drugs, Moderna does not.
TRADE:
We're just about at the .78 Fib retracement -which is a nice entry location. The $165 - 166 area.
One hour chart, clear double top forming and the RSI is weaker. Green arrow points recent average price. This is the first target at $147.
However when the MSM finally picks up this, they'll have NO choice, this stock potentially could trade into the single digits, but of course this will take more time.
The last couple of days average volume has increased by almost 100%. One of the reasons that $PFE and $MRNA have run up is the expectation that current out break in China will call for more of these drugs.
The counter argument to that is that Chinese will not engage the Americans directly about the war in Ukraine but are using this 'Outbreak' to disrupt supply chains further in the US. Think about it - outbreak, of what Omnicron?
Because this trade setup is fairly obviously there is a chance that price may go higher to pull shorts before returning lower - so be careful. Its not implausible that we go all the way up to about $180 which would be 100% retracement on weekly Fib before heading back down.
$PFE Key Levels, Analysis, & Targets $PFE Key Levels, Analysis, & Targets
Swing setup
1 at 47.59
1 at 45.65
2 at 41.06
4 at 38.36
8 at 34.40
(Then multiply by your multiplier (x5, x10, x100, x1000, etc to find your position size)
Looking for 15%, up to 20% if all targets hit…
---
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
IF you need anything analyzed Technically just comment with the Ticker and I’ll do it as soon as possible…
$PFESend $PFE to 175 Billion Dollar Market Cap. No more free government money to hold them up anymore. It's not a matter of IF, its a matter of WHEN. COVID IS GONEE RIGHT??? JUST MAGICALLY DISSAPEARED!!!!??? SO WILL THIS STOCK PRICE!!
June 16, 2023 $30 PUTS Loaded up.
Invalidated over $55. Would re-evaluate at that point.
Pfizer still in the game. PFE
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
PFE Long IdeaPFE Weekly Chart :
- Broke Downtrend trend line.
- Meet 10 EMA on the weekly = important resistance : we are seeing rejection of the 51-50 levels.
- Holding 48$ level is crucial for PFE to stay in it current uptrend. Above 51 PFE will likely go for the gap fill to reach around 52.70.
- With current market condition it is probable to have some kind of pullback next week : key point here is we need to see lower volume pullback with smaller candle than green candle. Optimal scenario is that we see a bounce back immediately after a pullback. That will signal relative strength and constant buying of the stock.
Long PfizerWhile the overall markets have been beaten down due to inflation, rate hikes combined with high asset prices, and the war in Ukraine, certain assets have been certainly rising like fuel and commodities. I'm almost looking at Pfizer as a commodity at this point since they have become so integral in the fight against COVID. Who knows what the future holds for Pfizer or the possibility of a 4th vaccination round. Right now all I know is that the price is bouncing nicely off the the 200-day SMA for the first time in a while. I'm also inclined to believe that the markets are due for a lift back up soon, so this could coincide with that idea, or even lead the charge.
Opinion only, not financial advice.
PFE Pfizer shortPfizer will re-enter the channel below current support. Looking for a re-test and breakdown of $45 before mid March. Fraud, vaccine ineffectiveness, and blatant disregard for human health are just a few of the concerns here. For those less inclined to believe in science, COVID is over and these vaccine companies cannot rely on any future income comparable to this pandemic.
an often mentioned healthcare stock (PFE)pfizer is one of those household names that has been getting constant attention since the outbreak of covid 19. right now it is at the tail end of a long downtrend, and healthcare is acting as a defensive play for risk off rotation. as long as the broader market bounces this should bounce.
Bias more on upside supported by 40days moving average27/02/22
Doji candle form at 50% Fibo supported by 40days Moving Average in weekly chart.
If next few candle support around 50% fibo area, this will determine a strong support area.
Otherwise, we may see $44 as next support
PFE still lower to go. Pfizer looks to test $50, and possibly the gap around 46~ if things get really ugly. Omicron is looking really promising as granting significant immunity after infection, which should reduce demand for further vaccinations. These vaccines companies have YEARS of covid priced into their stocks... Short side is getting a bit long in the tooth for new entries, however I am still holding 2/3rds of my puts across the board for these plays.
We posted our short thesis in another thread www.tradingview.com
PFE | Shorting the Vaccine 💉My current position and play is marked on the chart. I am expecting more selling pressure to come in now that we closed below the nearest zone. Expectation is that PFE will head toward the next zone located at the bottom. I will be trailing my stop once PFE begins the bearish move.
Pfizer more to drop
I see a 5 waves move up finished at $61 on 20th December, fallowed by an A-B-C standard correction.
Using the guideline of equality A=C and the Trend Based Fibonacci extension Pfizer will drop till about 1 level or $41.
This has support as well from $41 OCT 2021 level which is also the W4 level in the previous impulse movement.
Disclaimer:
This is my analysis and does not constitute financial advice
For more analysis like this ON DEMAND please leave me a message.
Pfizer: Ready to Shoot Lower? Pfizer - Short Term - We look to Sell at 49.33 (stop at 51.54)
The trend of lower highs is located at 53.50. Previous support located at 50.00. A move through bespoke support at 50.00 and we look for extended losses. Closed below the 20-day EMA. The medium term bias remains bearish.
Our profit targets will be 43.51 and 41.00
Resistance: 54.00 / 57.00 / 60.00
Support: 50.00 / 45.00 / 40.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
